newsfilter
← Latest News
GlobeNewswire·

Trevena to Release Second Quarter 2022 Financial Results on August 11, 2022

CHESTERBROOK, Pa., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced